Christian Gege

7PUBLICATIONS
18CO-AUTHORS
Biologically active moleculesAutoimmunityCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 27, 2026
Helicase-primase inhibitors as next-generation anti-HSV agents: from current clinical status to structure-activity relationships and patent coverage.

|Aug 19, 2025
Evaluation of the patent portfolio for helicase-primase inhibitor ABI-5366 of Assembly Biosciences Inc.

Christian Gege, Gerald Kleymann

|Apr 16, 2025
Identification of JNJ-61803534, a RORγt Inverse Agonist for the Treatment of Psoriasis.

Olaf Kinzel, Steven D Goldberg, Maxwell D Cummings

|Sep 12, 2024
Helicase-primase inhibitors for the treatment of herpes simplex virus infections - patent evaluation of WO2023/225162 from Gilead Sciences Inc.

Christian Gege, Gerald Kleymann

|Jun 18, 2024
Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti-SARS-CoV-2 Activity.

Christian Gege, Friedrich Hahn, Christina Wangen

|Jun 17, 2021
A helicase-primase drug candidate with sufficient target tissue exposure affects latent neural herpes simplex virus infections.

Christian Gege, Fernando J Bravo, Nadja Uhlig

Pageof 2

Frequent Collaborators

1 joint publications

Fabian Mayr

1 joint publications

Ulrike Garscha

1 joint publications

Birgit Waltenberger

1 joint publications

Stefan Schwaiger